Long term follow-up of the Intergroup Exemestane Study (IES)

PURPOSE: The Intergroup Exemestane Study (IES), an investigator-led study in 4724 postmenopausal patients with early breast cancer (ISRCTN11883920), has previously demonstrated that switching adjuvant endocrine therapy after 2-3 years tamoxifen to exemestane is associated with clinically relevant im...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Clin Oncol
Main Authors: Morden, James P, Alvarez, Isabel, Bertelli, Gianfilippo, Coates, Alan S, Coleman, Robert, Fallowfield, Lesley, Jassem, Jacek, Jones, Stephen, Kilburn, Lucy, Lønning, Per E., Ortmann, Olaf, Snowdon, Claire, van de Velde, Cornelis, Andersen, Jørn, Del Mastro, Lucia, Dodwell, David, Holmberg, Stig, Nicholas, Hanna, Paridaens, Robert, Bliss, Judith M, Coombes, R. Charles
Formato: Artigo
Idioma:Inglês
Publicado em: 2017
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6175047/
https://ncbi.nlm.nih.gov/pubmed/28467729
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2016.70.5640
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados